Table 2. Clinicopathologic features of patients included in the study.
| Feature | n (%) | Median (Range) |
|---|---|---|
| Sex
Male
Female |
352 (58.5%)
250 (41.5%) |
|
| Age, year |
63.11 (15.75 – 94.4) |
|
| Largest basal tumour diameter, mm |
14.3 (4.1 – 23.8) |
|
| Epithelioid cellularity
Absent
Present
Unknown |
231 (38.4%)
341 (56.6%)
30 (5%) |
|
| Anterior margin
post-ora
pre-ora |
401 (66.6%)
201 (33.4%) |
|
| Extra-ocular spread
No
Yes |
525 (87.2%)
77 (12.8%) |
|
| Ciliary body involvement
No
Yes
Unknown |
401 (66.7%)
200 (33.2%)
1 (0.1%) |
|
| TNM stage
T1
T2
T3
T4
Unknown |
96 (15.9%)
159 (26.4%)
224 (37.2%)
119 (19.8%)
4 (0.7%) |
|
| Treatment
Brachytherapy
Scleral resection
Enucleation
Proton beam therapy
Endoresection
Treated elsewhere
Other |
87 (14.4%)
48 (8%)
312 (51.8%)
89 (14.8%)
38 (6.3%)
18 (3%)
10 (1.7%) |
|
| Followup time, year | 3.08 (0.07 – 19.7) |